# Protective Effect of N-acetylcysteine Against From Ototoxicity

> **NCT01271088** · PHASE2,PHASE3 · COMPLETED · sponsor: **TC Erciyes University** · enrollment: 60 (actual)

## Conditions studied

- Hearing Loss, Extreme

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT01271088
- **Lead sponsor:** TC Erciyes University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01271088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01271088, "Protective Effect of N-acetylcysteine Against From Ototoxicity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01271088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*